Article

Researchers testing a compound treatment for AMD

Gainsville, FL-Scientists at the University of Florida (UF) and researchers in New Hampshire, Minnesota, and Arizona are conducting a new research study, testing an anti-inflammatory compound that has been injected into the eyes of patients with age-related macular degeneration (AMD).

Gainsville, FL-Scientists at the University of Florida (UF) and researchers in New Hampshire, Minnesota, and Arizona are conducting a new research study, testing an anti-inflammatory compound that has been injected into the eyes of patients with age-related macular degeneration (AMD).

The scientists are testing the safety and effectiveness of a synthetic peptide.

The complement inhibitors (Compstatin) developed by Potentia Pharmaceuticals, which is funding the safety trial at UF, have been shown to prevent the inflammatory response that accompanies both wet and dry AMD in animal studies.

POT-4, a derivative of the peptide, has been shown to be a much more active version of the original compound.

"There are now multiple reports that these complement proteins may be over stimulated in wet [AMD]," Kaushal said.

The first three patients of the study have been given the injections and a committee will evaluate the safety of the peptide in the eye. If it is successful another 12 will be tested.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.